Using CRISPR¿¿¿Cas9 to correct mutations in human induced pluripotent stem cells (hiPSC) from patients with schizophrenia who have mutations in DLG2

Project Details

StatusFinished
Effective start/end date5/06/174/08/17

Funding

  • UK-based charities: £1,940.00